	US 12,153,048 B2
	Monoclonal antibody that binds a MERS-coronavirus
Hyung Joo Kwon, Cheongju-si (KR); Byoung Kwon Park, Chuncheon-si (KR); and Dong Bum Kim, Chuncheon-si (KR)
Assigned to Industry Academic Cooperation Foundation, Hallym University, Chuncheon-si (KR)
Appl. No. 17/268,503
Filed by Industry Academic Cooperation Foundation, Hallym University, Chuncheon-si (KR)
PCT Filed Aug. 13, 2019, PCT No. PCT/KR2019/010272 § 371(c)(1), (2) Date Feb. 15, 2021, PCT Pub. No. WO2020/036403, PCT Pub. Date Feb. 20, 2020.
Claims priority of application No. 10-2018-0096102 (KR), filed on Aug. 17, 2018.
Prior Publication US 2021/0238261 A1, Aug. 5, 2021
Int. Cl. C07K 16/08 (2006.01); C07K 16/10 (2006.01); G01N 33/569 (2006.01)

CPC G01N 33/56983 (2013.01) [C07K 16/1002 (2023.08); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); G01N 2333/165 (2013.01)]

2 Claims

1. A monoclonal antibody that specifically binds a MERS coronavirus (MERS-CoV) and to the amino acid sequence of SEQ ID NO: 10, said antibody comprising a heavy chain variable domain consisting of an amino acid sequence of SEO ID NO: 7 and a light chain variable domain consisting of an amino sequence of SEQ ID NO: 8, wherein the antibody comprises 6 CDRs with the amino acid sequences of SEQ ID NO: 1-6.